Helicobacter pylori infection. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: (dual regimen): amoxicillin 1000 mg every 12 hours (Farabi pharmaceutical CO., Iran) and pantoprazole 40 mg every 12 hours (Tehranchemie CO., Iran) for 14 days and
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age more than 18 years Confirm diagnosis of H. pylori infection by stool antigen test No previous treatment of H. pylori infection Patient consent to participate in the study
Exclusion criteria
Exclusion criteria: Use of antibiotics or nonsteroidal anti-inflammatory drugs (NSAIDs) in the last 4 weeks allergy to any of the studied drugs History of gastric surgery or the presence of a serious concomitant disease such as cancer, Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence of Helicobacter pylori infection. Timepoint: Two weeks after the end of treatment. Method of measurement: Assess the presence of infection based on Stool Antigen Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment complication. Timepoint: Patients clinical visits every two weeks and fallow up by phone call every week. Method of measurement: Presence of nausea, vomiting and any allergic reactions based on clinical information. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamira Mohammadi
Ahvaz University of Medical Sciences
Outcome results
None listed